JP2022516631A5 - - Google Patents

Info

Publication number
JP2022516631A5
JP2022516631A5 JP2021538743A JP2021538743A JP2022516631A5 JP 2022516631 A5 JP2022516631 A5 JP 2022516631A5 JP 2021538743 A JP2021538743 A JP 2021538743A JP 2021538743 A JP2021538743 A JP 2021538743A JP 2022516631 A5 JP2022516631 A5 JP 2022516631A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
disease
substituted
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021538743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022516631A (ja
JP7566753B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/012268 external-priority patent/WO2020142748A1/en
Publication of JP2022516631A publication Critical patent/JP2022516631A/ja
Publication of JP2022516631A5 publication Critical patent/JP2022516631A5/ja
Application granted granted Critical
Publication of JP7566753B2 publication Critical patent/JP7566753B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021538743A 2019-01-03 2020-01-03 転写因子ｅｂポリペプチドレベルを増加させるための方法および材料 Active JP7566753B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962788049P 2019-01-03 2019-01-03
US62/788,049 2019-01-03
US201962879374P 2019-07-26 2019-07-26
US62/879,374 2019-07-26
PCT/US2020/012268 WO2020142748A1 (en) 2019-01-03 2020-01-03 Methods and materials for increasing transcription factor eb polypeptide levels

Publications (3)

Publication Number Publication Date
JP2022516631A JP2022516631A (ja) 2022-03-01
JP2022516631A5 true JP2022516631A5 (https=) 2023-01-06
JP7566753B2 JP7566753B2 (ja) 2024-10-15

Family

ID=71406977

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021538743A Active JP7566753B2 (ja) 2019-01-03 2020-01-03 転写因子ｅｂポリペプチドレベルを増加させるための方法および材料

Country Status (12)

Country Link
US (2) US12286442B2 (https=)
EP (1) EP3906033A4 (https=)
JP (1) JP7566753B2 (https=)
KR (1) KR102904932B1 (https=)
CN (1) CN113316453B (https=)
AU (1) AU2020204717B2 (https=)
BR (1) BR112021012950A2 (https=)
CA (1) CA3123902A1 (https=)
IL (1) IL284403A (https=)
MX (1) MX2021008152A (https=)
SG (1) SG11202105685TA (https=)
WO (1) WO2020142748A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023533016A (ja) 2020-07-11 2023-08-01 ファイザー・インク 抗ウイルス性ヘテロアリールケトン誘導体
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
CZ309449B6 (cs) * 2020-12-24 2023-01-25 Ústav experimentální botaniky AV ČR, v. v. i. Chinazolinové deriváty jako selektivní inhibitory cyklooxygenázy-1
CN113248518B (zh) * 2021-06-21 2022-03-25 山东大学 嘧啶哌嗪类衍生物及其制备方法与应用
CN121941701A (zh) * 2023-07-28 2026-04-28 特兰埃克斯公司 用于治疗溶酶体病症的突变tfeb
CN119818678A (zh) * 2024-12-24 2025-04-15 广州医科大学附属妇女儿童医疗中心 Tfeb在制备变应性鼻炎的药物中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5886026A (en) 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
WO2002022605A1 (en) * 2000-09-15 2002-03-21 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
US20030158195A1 (en) 2001-12-21 2003-08-21 Cywin Charles L. 1,6 naphthyridines useful as inhibitors of SYK kinase
AU2003286711A1 (en) * 2002-10-25 2004-05-13 Vertex Pharmaceuticals Incorporated Indazolinone compositions useful as kinase inhibitors
CL2004000409A1 (es) 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US7198926B2 (en) * 2003-05-08 2007-04-03 E. I. Du Pont De Nemours And Company Preparation of (E)- and (Z)-2-methyl-2-butenoic acids
EP1622615A4 (en) 2003-05-13 2009-02-18 Smithkline Beecham Corp INHIBITORS OF THE INTEGRASE OF NAPHTHYRIDINE
WO2008157500A1 (en) * 2007-06-17 2008-12-24 Kalypsys, Inc. Aminoquinazoline cannabinoid receptor modulators for treatment of disease
CA2705303A1 (en) * 2007-11-07 2009-05-14 Foldrx Pharmaceuticals, Inc. Modulation of protein trafficking
US20110201608A1 (en) * 2008-08-05 2011-08-18 Boehringer Ingelheim International Gmbh Substituted naphthyridines and use thereof as medicines
CA2731926A1 (en) * 2008-08-05 2010-02-11 Boehringer Ingelheim International Gmbh 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
GB201007203D0 (en) 2010-04-29 2010-06-16 Glaxo Group Ltd Novel compounds
GB201007347D0 (en) 2010-04-30 2010-06-16 Karus Therapeutics Ltd Compounds
CN104812387A (zh) 2012-11-20 2015-07-29 霍夫曼-拉罗奇有限公司 取代的1,6-萘啶
CN107205976A (zh) * 2014-11-19 2017-09-26 拉什大学医学中心 用于治疗溶酶体病症的组合物和方法
WO2018089433A1 (en) 2016-11-08 2018-05-17 Navitor Pharmaceuticals, Inc. PHENYL mTORC INHIBITORS AND USES THEREOF
WO2018089499A1 (en) * 2016-11-08 2018-05-17 Navitor Pharmaceuticals, Inc. PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF
WO2018089493A1 (en) * 2016-11-08 2018-05-17 Navitor Pharmaceuticals, Inc. PYRROLE mTORC INHIBITORS AND USES THEREOF
WO2018191146A1 (en) * 2017-04-10 2018-10-18 Navitor Pharmaceuticals, Inc. Heteroaryl rheb inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2022516631A5 (https=)
JP7652865B2 (ja) Ｒｏｃｋ阻害剤としての重水素化合物
US20240352031A1 (en) Thieno[2,3-D]pyrimidin-4-one Derivatives as NMDAR Modulators and Uses Related Thereto
US20030176497A1 (en) Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
JP2013541596A5 (https=)
US7595403B2 (en) Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
CN1646538A (zh) 托吡酯盐及其组合物、制备方法和应用
JP2018537413A (ja) Ｃｆｔｒを調節するための化合物、組成物、および方法
PE20240655A1 (es) Derivados de acido 4-(2-fluoro-4-metoxi-5-3-(((1-metilciclobutil)metil)carbamoil)biciclo[2.2.1]heptan-2-il)carbamoil)fenoxi)-1-metilciclohexano-1-carboxilico y compuestos similares como moduladores de rxfp1 para el tratamiento de insuficiencia cardiaca
CN1078471A (zh) 药品
JP2010138206A (ja) 新規な複素環式化合物
US20250382309A1 (en) Methods and materials for increasing transcription factor eb polypeptide levels
JP6363164B2 (ja) ヒストンデアセチラーゼ阻害剤及びその組成物と使用方法
CA2471578A1 (en) Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
WO2010051819A1 (en) Novel 2,3-diamino-quinazolinone derivatives and their medical use
JP2014506602A5 (https=)
MXPA06003751A (es) Derivados de arilalquilcarbamatos, su preparacion y su aplicacion en terapeutica.
US20110312962A1 (en) Novel 2-morpholino-3-amido-pyridine derivatives and their medical use
JP2023536511A5 (https=)
CN1850779A (zh) β－榄香烯含氮衍生物及其制备方法和用途
US9388166B2 (en) 6-aminoindole derivatives as TRP channel antagonists
MXPA06003770A (es) Medios desechables en un panal absorbente.
US20110003867A1 (en) Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
RU2021122937A (ru) Способы и материалы для повышения уровней полипептида фактора транскрипции eb
US20110003865A1 (en) Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators